Literature DB >> 17691843

Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials.

Janssen L Vanderhooft1, Brenda K Mann, Glenn D Prestwich.   

Abstract

Synthetic extracellular matrix hydrogels can be used for three-dimensional cell culture, wound repair, and tissue engineering. Using the bifunctional electrophile poly(ethylene glycol) diacrylate (PEGDA), thiol-modified glycosaminoglycans and polypeptides can be cross-linked into biocompatible materials in the presence of cells or tissues. However, the rate of in situ cross-linking with PEGDA under physiological conditions may occur too slowly for clinical applications requiring a fast-curing preparation. To explore a wider range of cross-linking time courses, five homo-bifunctional PEG derivatives were synthesized and examined as cross-linking agents for thiol-modified derivatives of hyaluronan (HA). Thiol reaction rate constants were measured over a pH range of 7.4 to 8.6. The order of reactivity for the functional groups used was determined to be maleimide > iodoacetate > bromoacetate > iodoacetamide > acrylate > bromoacetamide, with rates increasing exponentially with increasing pH. The range of gelation times at physiological pH varied from less than 1 min to over 2 h. Addition of the cross-linkers to cell culture medium showed minimal cytotoxicity toward primary human dermal fibroblasts at concentrations anticipated during in situ cross-linking. Moreover, hydrogels prepared from thiol-modified gelatin and thiol-modified HA were biocompatible and supported attachment and proliferation of fibroblasts and hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691843     DOI: 10.1021/bm0703564

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  27 in total

Review 1.  Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine.

Authors:  Glenn D Prestwich
Journal:  J Control Release       Date:  2011-04-14       Impact factor: 9.776

2.  Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties.

Authors:  Silviya P Zustiak; Jennie B Leach
Journal:  Biomacromolecules       Date:  2010-05-10       Impact factor: 6.988

3.  Modular extracellular matrices: solutions for the puzzle.

Authors:  Monica A Serban; Glenn D Prestwich
Journal:  Methods       Date:  2008-05       Impact factor: 3.608

4.  Silk fibroin and polyethylene glycol-based biocompatible tissue adhesives.

Authors:  Monica A Serban; Bruce Panilaitis; David L Kaplan
Journal:  J Biomed Mater Res A       Date:  2011-06-16       Impact factor: 4.396

5.  Synthesis and characterization of tyramine-based hyaluronan hydrogels.

Authors:  Aniq Darr; Anthony Calabro
Journal:  J Mater Sci Mater Med       Date:  2008-07-31       Impact factor: 3.896

6.  Synthesis, characterization and chondroprotective properties of a hyaluronan thioethyl ether derivative.

Authors:  Monica A Serban; Guanghui Yang; Glenn D Prestwich
Journal:  Biomaterials       Date:  2007-12-26       Impact factor: 12.479

7.  Thiol-selective fluorogenic probes for labeling and release.

Authors:  Vu Hong; Alexander A Kislukhin; M G Finn
Journal:  J Am Chem Soc       Date:  2009-07-29       Impact factor: 15.419

8.  Engineering a clinically-useful matrix for cell therapy.

Authors:  Glenn D Prestwich
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

9.  Engineered extracellular matrices with cleavable crosslinkers for cell expansion and easy cell recovery.

Authors:  Jianxing Zhang; Aleksander Skardal; Glenn D Prestwich
Journal:  Biomaterials       Date:  2008-09-02       Impact factor: 12.479

10.  Protein modification, bioconjugation, and disulfide bridging using bromomaleimides.

Authors:  Mark E B Smith; Felix F Schumacher; Chris P Ryan; Lauren M Tedaldi; Danai Papaioannou; Gabriel Waksman; Stephen Caddick; James R Baker
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.